The Potential Role of Monocyte Chemoattractant Protein-1 for Major Depressive Disorder

Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders

(2013) Sinead M. Gibney et al.   Journal of Neuroimmune Pharmacology

Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system

(2012) L.A. Carvalho et al.   JOURNAL OF AFFECTIVE DISORDERS

Cytokines: How important are they in mediating sickness?

(2012) David Chun-Hei Poon et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants

(2012) Seung-Yup Lee et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters

(2012) Shorena Janelidze et al.   PSYCHONEUROENDOCRINOLOGY

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors

(2012) Michael Maes et al.   INFLAMMOPHARMACOLOGY

Regulation of CCL2/MCP-1 production in astrocytes by desipramine and atomoxetine: Involvement of α2 adrenergic receptors

(2011) Ara E. Hinojosa et al.   BRAIN RESEARCH BULLETIN

Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis

(2011) Patricia A Zunszain et al.   NEUROPSYCHOPHARMACOLOGY

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression

(2011) Brian Leonard et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors

(2011) Michael Maes et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The Role of BDNF as a Mediator of Neuroplasticity in Bipolar Disorder

(2011) Iria Grande et al.   Psychiatry Investigation

Immune suppression and immune activation in depression

(2010) Joshua Blume et al.   BRAIN BEHAVIOR AND IMMUNITY

Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder

(2010) Piotr Gałecki et al.   JOURNAL OF AFFECTIVE DISORDERS

Regulation of MCP-1 production in brain by stress and noradrenaline-modulating drugs

(2010) Jose L. M. Madrigal et al.   JOURNAL OF NEUROCHEMISTRY

Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression

(2010) R C Shelton et al.   MOLECULAR PSYCHIATRY

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

(2009) Andrew H. Miller et al.   BIOLOGICAL PSYCHIATRY

Stress-induced neuroinflammation: mechanisms and new pharmacological targets

(2009) C.D. Munhoz et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Role of Chemokines in CNS Health and Pathology: A Focus on the CCL2/CCR2 and CXCL8/CXCR2 Networks

(2009) Bridgette D Semple et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Astrocyte-Derived MCP-1 Mediates Neuroprotective Effects of Noradrenaline

(2009) J. L. M. Madrigal et al.   JOURNAL OF NEUROSCIENCE

Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies

(2009) Jennifer M. Loftis et al.   NEUROBIOLOGY OF DISEASE

The MCP-1 Gene (SCYA2) and Mood Disorders: Preliminary Results of a Case-Control Association Study

(2009) A. Carlo Altamura et al.   NEUROIMMUNOMODULATION

Pro-inflammatory biomakers in depression: Treatment with venlafaxine

(2009) John E. Piletz et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression

(2008) Hideki Miura et al.   STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS